| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.8 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |